US 12291507
Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency
granted A61PA61P11/00
Quick answer
US patent 12291507 (Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency) held by CENTESSA PHARMACEUTICALS (UK) LIMITED expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CENTESSA PHARMACEUTICALS (UK) LIMITED
- Grant date
- Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P11/00